Abstract: Graves’ Disease is an autoimmune disease that affects the thyroid and is the most common cause of hyperthyroidism Signs and symptoms of hyperthyroidism may include exophthalmos irritability, muscle weakness, palpitations, diarrhea, and weight loss
The diagnosis may be suspected based on symptoms and confirmed with blood tests and radioiodin euptake. Typically blood tests show a raised T3 and T4, and serum thyroglobulin, low TSH, increased radioiodine uptake in all areas of the thyroid, and TSI antibodies. There are three treatment options: anti-thyroid medications such as methimazole, radioiodine therapy and thyroid surgery (Thyroidectomy). This review will focus on the approach to RAI therapy; discussing dose selection, patient preparation, and consideration before and after administering RAI, examining aspects of pre-treatment. Follow-up is lifelong with the aim of ensuring the patient remains euthyroid or on replacement therapy if there is evidence of hypothyroidism.
Keywords: Radioactive Iodine, Graves’ disease, Thyroid, Treatment, Medical Sciences.
Title: Radioiodine I-131 Therapy for Graves’ Disease
Author: Moosa Jeded Alenazi
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
